리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
한글목차
전기 자극 기기 세계 시장은 2030년까지 157억 달러에 달할 것으로 전망
2023년 92억 달러로 추정되는 전기 자극 기기 세계 시장은 2023년부터 2030년까지 연평균 8.0% 성장하여 2030년에는 157억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 통증 관리 애플리케이션은 CAGR 8.3%를 기록하여 분석 기간 종료 시점에 54억 달러에 도달할 것으로 예상됩니다. 신경학 및 운동 장애 관리 애플리케이션 분야의 성장률은 분석 기간 동안 CAGR 9.5%로 추정됩니다.
미국 시장 25억 달러로 추정, 중국은 CAGR 7.4%로 성장 전망
미국의 전기 자극 기기 시장은 2023년 25억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 24억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 7.4%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 7.3%와 6.4%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 약 6.5%의 CAGR로 성장할 것으로 예상됩니다.
세계 전기 자극 기기 시장 - 주요 동향 및 촉진요인 정리
전기 자극 기기는 어떻게 재활과 통증 관리에 혁명을 일으키고 있는가?
전기 자극 기기는 재활, 통증 관리 및 근력 재교육 분야에 변화를 일으키고 있습니다. 전기 펄스를 환부에 전달하여 신경과 근육을 자극하는 이 장비는 다양한 의료 현장에서 치료 효과를 가져오는데 사용됩니다. 경피적 전기신경자극(TENS), 기능적 전기자극(FES), 신경근 전기자극(NMES) 등의 기술은 부상이나 신경질환 환자의 통증을 완화하고, 근육 위축을 억제하며, 운동 기능을 개선하는 데 널리 사용되고 있습니다. 중추신경계의 자연적 작용을 모방하여, 이 장치는 최적의 기능을 하지 못하는 근육을 활성화하고 혈액 순환을 촉진하며 엔도르핀을 방출하여 통증 감각을 감소시킬 수 있습니다. 이 비침습적 접근 방식은 약물 진통제의 대안을 찾고 있거나 수술 후 회복기에 있는 환자에게 특히 유용하며, 삶의 질을 크게 향상시키고 회복의 길을 앞당길 수 있습니다.
어떤 기술 혁신이 전기 자극 기기의 기능을 향상시키는가?
전기 자극 기술의 혁신은 이러한 장치의 효과, 사용 편의성 및 접근성을 향상시키는 데 중점을 두고 있습니다. 최근의 발전에는 무선 기술을 통합하여 장치를 원격으로 조작할 수 있는 무선 기술의 통합이 포함되어 사용자의 편의성을 높이고 보다 유연한 치료 옵션을 가능하게 합니다. 또한, 환자가 일상 생활에서 사용할 수 있는 웨어러블 자극기 개발도 크게 진전되어 일상생활을 방해하지 않고 지속적인 치료와 모니터링을 할 수 있게 되었습니다. 또한, 전극 설계의 개선으로 인해 장치가 더 편안하고 전기 펄스를 표적 부위에 효율적으로 전달할 수 있게 되었습니다. 인공지능(AI)은 사용자의 신체로부터의 실시간 피드백을 기반으로 자극 패턴을 조정하고 개인의 필요에 따라 치료 결과를 최적화할 수 있는 알고리즘으로 큰 진전을 이루고 있는 또 다른 분야입니다. 이러한 기술적 강화는 환자의 결과를 개선할 뿐만 아니라 전기 자극을 현대 의학의 핵심 요소로 널리 채택하고 수용하는 데 기여하고 있습니다.
전기 자극 기기는 헬스케어의 지속가능성에 어떤 영향을 미치고 있는가?
전기 자극 기기는 약물이나 침습적 시술에 대한 의존도를 낮추는 비용 효율적인 비약물 치료 옵션을 제공함으로써 헬스케어의 지속가능성에 크게 기여할 수 있습니다. 이러한 장치로 통증을 관리하고 근육 기능을 촉진함으로써 의료 서비스 제공자는 종종 비용이 많이 들고 부작용과 중독 가능성이 있는 오피오이드 및 기타 진통제의 사용을 최소화할 수 있습니다. 또한, 전기 자극은 환자가 집에서 자신의 상태를 관리할 수 있게함으로써 반복적인 진료와 장기 입원의 필요성을 줄여 전반적인 의료 비용과 자원 사용을 줄일 수 있습니다. 이러한 변화는 의료 시스템의 경제적 부담을 줄일 뿐만 아니라 환자가 자신의 치료를 더 잘 통제할 수 있도록 하여 전반적인 건강 결과와 환자 만족도를 향상시킬 수 있습니다.
전기 자극 기기 시장의 성장을 촉진하는 추세는 무엇인가?
전기 자극 기기 시장은 고령화, 만성 통증 및 신경 질환의 유병률 증가, 비침습적 치료에 대한 인식과 수용성 증가 등 몇 가지 주요 트렌드에 힘입어 강력한 성장세를 보이고 있습니다. 인구 고령화에 따라 관절염, 근력 약화, 신경 퇴행성 질환 등 전기 자극을 통해 개선할 수 있는 노화 관련 질환에 대한 효과적인 치료법에 대한 수요가 증가하고 있습니다. 또한, 전 세계적으로 만성 통증에 대한 부담이 증가함에 따라 약물에 의존하지 않는 대체 요법을 찾는 환자와 의료진이 늘어나면서 전기 자극 장치에 대한 수요가 증가하고 있습니다. 또한, 전기 자극 기기의 사용 편의성과 효과성을 향상시키는 기술 발전도 전기 자극 기기 도입 확대에 기여하고 있습니다. 또한, 신흥국의 의료 인프라와 서비스 확대는 이러한 혁신적인 치료법의 보급에 더 많은 기회를 제공하고 있습니다. 이러한 추세는 현대 의료에서 전기자극의 역할이 확대되고 있으며, 전 세계 환자의 삶을 개선할 수 있는 잠재력이 있다는 것을 강조하고 있습니다.
조사 대상 기업 예시(총 18건)
Abbott Laboratories
Boston Scientific Corporation
BTL Industries, Inc.
Cogentix Medical, Inc.
Cyberonics, Inc.
DJO Global, Inc.
Medtronic PLC
NeuroMetrix, Inc.
Nevro Corp.
Zynex Medical
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Electrical Stimulation Devices Market to Reach US$15.7 Billion by 2030
The global market for Electrical Stimulation Devices estimated at US$9.2 Billion in the year 2023, is expected to reach US$15.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Pain Management Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Neurological & Movement Disorder Management Application segment is estimated at 9.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.4% CAGR
The Electrical Stimulation Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.
Global Electrical Stimulation Devices Market - Key Trends and Drivers Summarized
How Are Electrical Stimulation Devices Revolutionizing Rehabilitation and Pain Management?
Electrical stimulation devices are transforming the fields of rehabilitation, pain management, and muscular retraining. These devices, which deliver electrical pulses to affected areas, are used to stimulate nerves and muscles, providing therapeutic benefits in various medical settings. Techniques such as Transcutaneous Electrical Nerve Stimulation (TENS), Functional Electrical Stimulation (FES), and Neuromuscular Electrical Stimulation (NMES) are widely utilized to alleviate pain, reduce muscle atrophy, and improve motor function in patients with injuries or neurological conditions. By mimicking the natural action of the central nervous system, these devices can activate muscles that are not functioning optimally, enhance blood circulation, and release endorphins to reduce pain sensations. This non-invasive approach is particularly valuable for patients seeking alternatives to pharmaceutical pain relief or those in postoperative recovery, significantly enhancing quality of life and accelerating the path to recovery.
What Innovations Are Enhancing the Functionality of Electrical Stimulation Devices?
Innovation in electrical stimulation technology is focused on enhancing the effectiveness, user-friendliness, and accessibility of these devices. Modern advancements include the integration of wireless technologies, which allow for remote control of the devices, increasing convenience for users and enabling more flexible treatment options. There is also significant progress in developing wearable stimulation devices that patients can use in their everyday lives, providing continuous therapy and monitoring without disrupting daily activities. Moreover, improvements in electrode design have made devices more comfortable and efficient at delivering electrical pulses to the target areas. Artificial intelligence (AI) is another area where substantial strides are being made, with algorithms that can adapt stimulation patterns based on real-time feedback from the user's body, optimizing therapeutic outcomes tailored to individual needs. These technological enhancements not only improve patient outcomes but also contribute to broader adoption and acceptance of electrical stimulation as a critical component of modern medical care.
How Do Electrical Stimulation Devices Impact Healthcare Sustainability?
Electrical stimulation devices contribute significantly to healthcare sustainability by offering cost-effective, non-pharmacological treatment options that reduce dependence on medication and invasive procedures. By managing pain and facilitating muscle function with these devices, healthcare providers can minimize the use of opioids and other pain-relief drugs, which are often expensive and have the potential for side effects and addiction. Additionally, electrical stimulation can reduce the need for repeated medical visits or prolonged hospital stays by enabling patients to manage their conditions at home, thereby decreasing overall healthcare costs and resource use. This shift not only alleviates the financial burden on healthcare systems but also empowers patients with more control over their treatment, leading to better overall health outcomes and patient satisfaction.
What Trends Are Driving Growth in the Electrical Stimulation Devices Market?
The market for electrical stimulation devices is experiencing robust growth driven by several key trends, including the aging global population, the rising prevalence of chronic pain and neurological disorders, and increased awareness and acceptance of non-invasive therapies. As the population ages, there is a higher demand for effective treatments for age-related conditions such as arthritis, muscle weakness, and neurodegenerative diseases, which can be ameliorated through electrical stimulation. Furthermore, as the global burden of chronic pain increases, more patients and healthcare providers are looking for alternative therapies that do not rely on medications, thereby fueling demand for electrical stimulation devices. Advances in technology that make these devices more user-friendly and effective also contribute to their growing adoption. Additionally, the expansion of healthcare infrastructure and services in emerging economies provides further opportunities for the penetration of these innovative therapies. These trends collectively underscore the expanding role of electrical stimulation in contemporary healthcare and its potential to enhance the lives of patients worldwide.
Select Competitors (Total 18 Featured) -
Abbott Laboratories
Boston Scientific Corporation
BTL Industries, Inc.
Cogentix Medical, Inc.
Cyberonics, Inc.
DJO Global, Inc.
Medtronic PLC
NeuroMetrix, Inc.
Nevro Corp.
Zynex Medical
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Electrical Stimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rise in Neurological Disorders Globally Drives Demand for Electrical Stimulation Devices
Technological Breakthroughs in Neuromodulation Propel Market Growth
Aging Populations Worldwide Expand Addressable Market for Pain Management Therapies
Innovations in Wearable Electrical Stimulation Devices Strengthen Business Cases
Expanding Insurance Coverage for Rehabilitation Devices Accelerates Market Adoption
Market Trends Toward Home-based Therapy and the Rise of Telehealth
Increasing Clinical Evidence Supporting the Efficacy of Electrical Stimulation
Expanding Application in Veterinary Medicine Opens New Market Avenues
Market Dynamics Driven by Increasing Healthcare Expenditure
Research Focus on Deep Brain Stimulation and Its Expanding Indications
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Spinal Cord Stimulation (SCS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Deep Brain Stimulation (DBS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Neurological & Movement Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Musculoskeletal Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Metabolism & GIT Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Electrical Stimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 32: World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
CHINA
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 68: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 71: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 77: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Germany 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 83: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Italy 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 89: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: UK Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: UK 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of World Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
TABLE 107: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of World Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030